CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / Common Stock
Shares outstanding
123,180,519
Total 13F shares
54,196,334
Share change
-512,358
Total reported value
$169,201,579
Put/Call ratio
44%
Price per share
$3.12
Number of holders
98
Value change
+$2,782,969
Number of buys
62
Number of sells
35

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q2 2018

As of 30 Jun 2018, CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,196,334 shares. The largest 10 holders included Broadfin Capital, LLC, BlackRock Inc., Consonance Capital Management LP, venBio Select Advisor LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, MORGAN STANLEY, ARMISTICE CAPITAL, LLC, MANGROVE PARTNERS, and MILLENNIUM MANAGEMENT LLC. This page lists 98 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders
97
Q2 2018 holders
98
Holder diff
1
Investor Q1 2018 Shares Q2 2018 Shares Share Diff Share Chg % Q1 2018 Value $ Q2 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.